417 related articles for article (PubMed ID: 30021351)
1. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
Jiang XM; Yu XN; Liu TT; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Huang XX; Dong L; Janssen HLA; Shen XZ; Zhu JM
Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351
[TBL] [Abstract][Full Text] [Related]
2. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
3. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
Tian T; Fu X; Lu J; Ruan Z; Nan K; Yao Y; Yang Y
J Biochem Mol Toxicol; 2018 Aug; 32(8):e22167. PubMed ID: 29968951
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
Tu K; Liu Z; Yao B; Han S; Yang W
Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
[TBL] [Abstract][Full Text] [Related]
6. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
Guo XL; Wang HB; Yong JK; Zhong J; Li QH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
Chang RM; Xu JF; Fang F; Yang H; Yang LY
Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
Meng F; Henson R; Wehbe-Janek H; Ghoshal K; Jacob ST; Patel T
Gastroenterology; 2007 Aug; 133(2):647-58. PubMed ID: 17681183
[TBL] [Abstract][Full Text] [Related]
9. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
Xiao ZD; Jiao CY; Huang HT; He LJ; Zhao JJ; Lu ZY; Liu LX
Int J Clin Exp Pathol; 2014; 7(7):4039-44. PubMed ID: 25120782
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.
Zhang X; Chen Y; Zhao P; Zang L; Zhang Z; Wang X
Leuk Lymphoma; 2017 Apr; 58(4):932-940. PubMed ID: 27830963
[TBL] [Abstract][Full Text] [Related]
11. Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog.
Wang X; He H; Lu Y; Ren W; Teng KY; Chiang CL; Yang Z; Yu B; Hsu S; Jacob ST; Ghoshal K; Lee LJ
Biochim Biophys Acta; 2015 Jan; 1853(1):244-53. PubMed ID: 25447674
[TBL] [Abstract][Full Text] [Related]
12. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
[TBL] [Abstract][Full Text] [Related]
13. MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN.
Lin H; Huang ZP; Liu J; Qiu Y; Tao YP; Wang MC; Yao H; Hou KZ; Gu FM; Xu XF
Sci Rep; 2018 Jul; 8(1):10461. PubMed ID: 29992971
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.
Chang S; Chen B; Wang X; Wu K; Sun Y
BMC Cancer; 2017 Apr; 17(1):248. PubMed ID: 28388883
[TBL] [Abstract][Full Text] [Related]
18. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
Fu X; Liu M; Qu S; Ma J; Zhang Y; Shi T; Wen H; Yang Y; Wang S; Wang J; Nan K; Yao Y; Tian T
J Exp Clin Cancer Res; 2018 Mar; 37(1):52. PubMed ID: 29530052
[TBL] [Abstract][Full Text] [Related]
19. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
20. Pterostilbene increases PTEN expression through the targeted downregulation of microRNA-19a in hepatocellular carcinoma.
Qian YY; Liu ZS; Zhang Z; Levenson AS; Li K
Mol Med Rep; 2018 Apr; 17(4):5193-5201. PubMed ID: 29393488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
